Transcripts
Myriad Genetics (MYGN) earnings call transcripts
Earnings call transcripts for Myriad Genetics Inc., with a summary, the guidance given, and what analysts pressed on.
- Q2 2026 earnings call
Management framed the call around payer-driven reimbursement friction, a sharper cancer-care focus and efficiency measures, while acknowledging weaker prenatal trends and cutting guidance.
Jul 30, 2026Cautious-0.30